Amplicon details

Amplicon:

215 bp
1     ctcaccttgc tcctgccgag aaagtatcca tcatggctga tgcaatgcgg
51    cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa
101   acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc
151   aggatgatct ggacgaagag catcaggggc tcgcgccagc cgaactgttc
201   gccaggctca aggcg 

An identical amplicon is found in the following matches:

Record ID Database Record description Record length Taxon Method Amplicon size Match details
LZ099022.1 emblrelpat JP 2017121247-A/47: Isoprene syntha... 11386 bp synthetic construct QL-ELE-00-002 215 bp View
LZ099205.1 emblrelpat JP 2017123856-A/20: COMPOSITIONS AN... 8804 bp synthetic construct QL-ELE-00-002 215 bp View
LZ099218.1 emblrelpat JP 2017123856-A/33: COMPOSITIONS AN... 10992 bp synthetic construct QL-ELE-00-002 215 bp View
LZ099235.1 emblrelpat JP 2017123856-A/50: COMPOSITIONS AN... 6912 bp synthetic construct QL-ELE-00-002 215 bp View
LZ099236.1 emblrelpat JP 2017123856-A/51: COMPOSITIONS AN... 7902 bp synthetic construct QL-ELE-00-002 215 bp View
MO933606.1 emblrelpat Sequence 10 from patent US 10582702. 7473 bp unidentified QL-ELE-00-002 215 bp View
MO935232.1 emblrelpat Sequence 56 from patent US 10584317. 5904 bp unidentified QL-ELE-00-002 215 bp View
LZ100809.1 emblrelpat JP 2017516839-A/51: HYBRID IMMUNOGL... 824 bp synthetic construct QL-ELE-00-002 215 bp View
LZ100810.1 emblrelpat JP 2017516839-A/52: HYBRID IMMUNOGL... 6739 bp synthetic construct QL-ELE-00-002 215 bp View
LZ100811.1 emblrelpat JP 2017516839-A/53: HYBRID IMMUNOGL... 6103 bp synthetic construct QL-ELE-00-002 215 bp View
LZ177956.1 emblrelpat JP 2017140019-A/24: PRODUCTION OF T... 1568 bp synthetic construct QL-ELE-00-002 215 bp View
LZ180351.1 emblrelpat JP 2017131227-A/2: FUMARYLACETOACET... 4657 bp synthetic construct QL-ELE-00-002 215 bp View
LZ186239.1 emblrelpat JP 2017141261-A/2: THERAPEUTIC COMP... 5484 bp synthetic construct QL-ELE-00-002 215 bp View
LZ186240.1 emblrelpat JP 2017141261-A/3: THERAPEUTIC COMP... 7051 bp synthetic construct QL-ELE-00-002 215 bp View
LZ186241.1 emblrelpat JP 2017141261-A/4: THERAPEUTIC COMP... 7340 bp synthetic construct QL-ELE-00-002 215 bp View
LZ186243.1 emblrelpat JP 2017141261-A/6: THERAPEUTIC COMP... 7253 bp synthetic construct QL-ELE-00-002 215 bp View
LZ186244.1 emblrelpat JP 2017141261-A/7: THERAPEUTIC COMP... 6398 bp synthetic construct QL-ELE-00-002 215 bp View
LZ186245.1 emblrelpat JP 2017141261-A/8: THERAPEUTIC COMP... 6326 bp synthetic construct QL-ELE-00-002 215 bp View
LZ186246.1 emblrelpat JP 2017141261-A/9: THERAPEUTIC COMP... 6517 bp synthetic construct QL-ELE-00-002 215 bp View
LZ186247.1 emblrelpat JP 2017141261-A/10: THERAPEUTIC COM... 7965 bp synthetic construct QL-ELE-00-002 215 bp View


Related publications:

Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101. 

Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.